Expression of heparanase in basal cell carcinoma and squamous cell carcinoma

Abstract: Background: Heparanase is an enzyme that cleaves heparan sulfate chains. Oligosaccharides generated by heparanase induce tumor progression. Basal cell carcinoma and squamous cell carcinoma comprise types of nonmelanoma skin cancer. Objectives: Evaluate the glycosaminoglycans profile and expression of heparanase in two human cell lines established in culture, immortalized skin keratinocyte (HaCaT) and squamous cell carcinoma (A431) and also investigate the expression of heparanase in basal cell carcinoma, squamous cell carcinoma and eyelid skin of individuals not affected by the disease (control). Methods: Glycosaminoglycans were quantified by electrophoresis and indirect ELISA method. The heparanase expression was analyzed by quantitative RT-PCR (qRTPCR). Results: The A431 strain showed significant increase in the sulfated glycosaminoglycans, increased heparanase expression and decreased hyaluronic acid, comparing to the HaCaT lineage. The mRNA expression of heparanase was significantly higher in Basal cell carcinoma and squamous cell carcinoma compared with control skin samples. It was also observed increased heparanase expression in squamous cell carcinoma compared to the Basal cell carcinoma. Conclusion: The glycosaminoglycans profile, as well as heparanase expression are different between HaCaT and A431 cell lines. The increased expression of heparanase in Basal cell carcinoma and squamous cell carcinoma suggests that this enzyme could be a marker for the diagnosis of such types of non-melanoma cancers, and may be useful as a target molecule for future alternative treatment.

Saved in:
Bibliographic Details
Main Authors: Pinhal,Maria Aparecida Silva, Almeida,Maria Carolina Leal, Costa,Alessandra Scorse, Theodoro,Thérèse Rachell, Serrano,Rodrigo Lorenzetti, Machado Filho,Carlos D'Apparecida Santos
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Dermatologia 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000500595
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0365-05962016000500595
record_format ojs
spelling oai:scielo:S0365-059620160005005952016-11-04Expression of heparanase in basal cell carcinoma and squamous cell carcinomaPinhal,Maria Aparecida SilvaAlmeida,Maria Carolina LealCosta,Alessandra ScorseTheodoro,Thérèse RachellSerrano,Rodrigo LorenzettiMachado Filho,Carlos D'Apparecida Santos Carcinoma, basal cell Carcinoma, squamous cell Glycosaminoglycans Hyaluronic acid Neoplasms Polymerase chain reaction Skin neoplasms Abstract: Background: Heparanase is an enzyme that cleaves heparan sulfate chains. Oligosaccharides generated by heparanase induce tumor progression. Basal cell carcinoma and squamous cell carcinoma comprise types of nonmelanoma skin cancer. Objectives: Evaluate the glycosaminoglycans profile and expression of heparanase in two human cell lines established in culture, immortalized skin keratinocyte (HaCaT) and squamous cell carcinoma (A431) and also investigate the expression of heparanase in basal cell carcinoma, squamous cell carcinoma and eyelid skin of individuals not affected by the disease (control). Methods: Glycosaminoglycans were quantified by electrophoresis and indirect ELISA method. The heparanase expression was analyzed by quantitative RT-PCR (qRTPCR). Results: The A431 strain showed significant increase in the sulfated glycosaminoglycans, increased heparanase expression and decreased hyaluronic acid, comparing to the HaCaT lineage. The mRNA expression of heparanase was significantly higher in Basal cell carcinoma and squamous cell carcinoma compared with control skin samples. It was also observed increased heparanase expression in squamous cell carcinoma compared to the Basal cell carcinoma. Conclusion: The glycosaminoglycans profile, as well as heparanase expression are different between HaCaT and A431 cell lines. The increased expression of heparanase in Basal cell carcinoma and squamous cell carcinoma suggests that this enzyme could be a marker for the diagnosis of such types of non-melanoma cancers, and may be useful as a target molecule for future alternative treatment.info:eu-repo/semantics/openAccessSociedade Brasileira de DermatologiaAnais Brasileiros de Dermatologia v.91 n.5 20162016-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000500595en10.1590/abd1806-4841.20164957
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pinhal,Maria Aparecida Silva
Almeida,Maria Carolina Leal
Costa,Alessandra Scorse
Theodoro,Thérèse Rachell
Serrano,Rodrigo Lorenzetti
Machado Filho,Carlos D'Apparecida Santos
spellingShingle Pinhal,Maria Aparecida Silva
Almeida,Maria Carolina Leal
Costa,Alessandra Scorse
Theodoro,Thérèse Rachell
Serrano,Rodrigo Lorenzetti
Machado Filho,Carlos D'Apparecida Santos
Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
author_facet Pinhal,Maria Aparecida Silva
Almeida,Maria Carolina Leal
Costa,Alessandra Scorse
Theodoro,Thérèse Rachell
Serrano,Rodrigo Lorenzetti
Machado Filho,Carlos D'Apparecida Santos
author_sort Pinhal,Maria Aparecida Silva
title Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
title_short Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
title_full Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
title_fullStr Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
title_full_unstemmed Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
title_sort expression of heparanase in basal cell carcinoma and squamous cell carcinoma
description Abstract: Background: Heparanase is an enzyme that cleaves heparan sulfate chains. Oligosaccharides generated by heparanase induce tumor progression. Basal cell carcinoma and squamous cell carcinoma comprise types of nonmelanoma skin cancer. Objectives: Evaluate the glycosaminoglycans profile and expression of heparanase in two human cell lines established in culture, immortalized skin keratinocyte (HaCaT) and squamous cell carcinoma (A431) and also investigate the expression of heparanase in basal cell carcinoma, squamous cell carcinoma and eyelid skin of individuals not affected by the disease (control). Methods: Glycosaminoglycans were quantified by electrophoresis and indirect ELISA method. The heparanase expression was analyzed by quantitative RT-PCR (qRTPCR). Results: The A431 strain showed significant increase in the sulfated glycosaminoglycans, increased heparanase expression and decreased hyaluronic acid, comparing to the HaCaT lineage. The mRNA expression of heparanase was significantly higher in Basal cell carcinoma and squamous cell carcinoma compared with control skin samples. It was also observed increased heparanase expression in squamous cell carcinoma compared to the Basal cell carcinoma. Conclusion: The glycosaminoglycans profile, as well as heparanase expression are different between HaCaT and A431 cell lines. The increased expression of heparanase in Basal cell carcinoma and squamous cell carcinoma suggests that this enzyme could be a marker for the diagnosis of such types of non-melanoma cancers, and may be useful as a target molecule for future alternative treatment.
publisher Sociedade Brasileira de Dermatologia
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000500595
work_keys_str_mv AT pinhalmariaaparecidasilva expressionofheparanaseinbasalcellcarcinomaandsquamouscellcarcinoma
AT almeidamariacarolinaleal expressionofheparanaseinbasalcellcarcinomaandsquamouscellcarcinoma
AT costaalessandrascorse expressionofheparanaseinbasalcellcarcinomaandsquamouscellcarcinoma
AT theodorothereserachell expressionofheparanaseinbasalcellcarcinomaandsquamouscellcarcinoma
AT serranorodrigolorenzetti expressionofheparanaseinbasalcellcarcinomaandsquamouscellcarcinoma
AT machadofilhocarlosdapparecidasantos expressionofheparanaseinbasalcellcarcinomaandsquamouscellcarcinoma
_version_ 1756412538597146624